AbbVie Total Current Assets increased by 15.4% to $33.53B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.2%, from $27.68B to $33.53B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows an upward trend with a 3.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Higher levels indicate stronger short-term liquidity, though excessive levels may suggest inefficient capital allocation.
The sum of all assets that are expected to be converted into cash or consumed within one year. This provides a snapshot...
Compared against current liabilities to determine the current ratio, a standard measure of short-term financial health.
total_current_assets| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $26.00B | $28.96B | $27.93B | $26.51B | $29.10B | $30.36B | $28.46B | $26.49B | $28.85B | $33.22B | $33.00B | $38.87B | $33.82B | $27.79B | $25.58B | $27.68B | $29.26B | $28.54B | $29.06B | $33.53B |
| QoQ Change | — | +11.4% | -3.6% | -5.1% | +9.8% | +4.3% | -6.3% | -6.9% | +8.9% | +15.2% | -0.7% | +17.8% | -13.0% | -17.8% | -7.9% | +8.2% | +5.7% | -2.5% | +1.8% | +15.4% |
| YoY Change | — | — | — | — | +11.9% | +4.9% | +1.9% | -0.1% | -0.9% | +9.4% | +15.9% | +46.7% | +17.2% | -16.4% | -22.5% | -28.8% | -13.5% | +2.7% | +13.6% | +21.2% |